2016
DOI: 10.5812/jamm.41832
|View full text |Cite
|
Sign up to set email alerts
|

Toxoplasmosis Among Patients with Immunocompromising Conditions: A Snapshot

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
24
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

7
1

Authors

Journals

citations
Cited by 16 publications
(24 citation statements)
references
References 16 publications
0
24
0
Order By: Relevance
“…1 A host's immunological status is the most important influencing factor in the course of T. gondii infection. 2 The infection is usually asymptomatic (albeit, latent) in immunocompetent individuals but is life-threatening in immunocompromised patients, including cancer patients, especially during chemotherapy. [2][3][4][5][6] The reactivation of latent toxoplasmosis may also arise in infection in immunocompromised patients.…”
Section: Introductionmentioning
confidence: 99%
“…1 A host's immunological status is the most important influencing factor in the course of T. gondii infection. 2 The infection is usually asymptomatic (albeit, latent) in immunocompetent individuals but is life-threatening in immunocompromised patients, including cancer patients, especially during chemotherapy. [2][3][4][5][6] The reactivation of latent toxoplasmosis may also arise in infection in immunocompromised patients.…”
Section: Introductionmentioning
confidence: 99%
“…More than one-third of the world human populations are T. gondii-IgG seropositive without any clinical symptoms (Robert-Gangneux & Darde, 2012). In fact, toxoplasmosis is usually asymptomatic in healthy individuals, but it always life threatening in immunocompromised patients (e.g., HIV/ AIDS, cancer, transplant recipients, and hemodialysis patients) (Abdoli et al, 2016;Robert-Gangneux & Darde, 2012). Hence, immunocompromised patients are presented as sensitive groups of toxoplasmosis and the infection is usually higher prevalent among these patients than healthy individuals (Abdoli et al, 2016;Robert-Gangneux & Darde, 2012).…”
Section: Dear Editormentioning
confidence: 99%
“…In fact, toxoplasmosis is usually asymptomatic in healthy individuals, but it always life threatening in immunocompromised patients (e.g., HIV/ AIDS, cancer, transplant recipients, and hemodialysis patients) (Abdoli et al, 2016;Robert-Gangneux & Darde, 2012). Hence, immunocompromised patients are presented as sensitive groups of toxoplasmosis and the infection is usually higher prevalent among these patients than healthy individuals (Abdoli et al, 2016;Robert-Gangneux & Darde, 2012). Surprisingly, the molecular results of Menati Rashno et al is inconsistence with the other reports, even in comparison with studies that detected toxoplasmosis in immunocompromised patients.…”
Section: Dear Editormentioning
confidence: 99%
“…The disease is dangerous for immunocompromised individuals such as those treated with immunosuppressive drugs, HIVpositive patients, cancer patients, etc. (7,8).…”
Section: Introductionmentioning
confidence: 99%